Detalhe da pesquisa
1.
A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.
Ophthalmic Res
; 66(1): 1030-1043, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37257422
2.
Mitigation and management strategies for ocular events associated with tisotumab vedotin.
Gynecol Oncol
; 165(2): 385-392, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277279
3.
Ferromagnetic Quantum Critical Point Avoided by the Appearance of Another Magnetic Phase in LaCrGe_{3} under Pressure.
Phys Rev Lett
; 117(3): 037207, 2016 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27472137
4.
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.
Invest New Drugs
; 32(6): 1246-57, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25142258
5.
The C-type lectin receptor CLECSF8 (CLEC4D) is expressed by myeloid cells and triggers cellular activation through Syk kinase.
J Biol Chem
; 287(31): 25964-74, 2012 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22689578
6.
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.
Clin Cancer Res
; 28(10): 2020-2029, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35165101
7.
First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors.
J Clin Oncol
; 38(16): 1824-1835, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32213105
8.
Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine.
Clin Cancer Res
; 25(6): 1727-1736, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413525
9.
Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine.
Ophthalmology
; 115(3): 483-7, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18201764
10.
Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas.
Clin Cancer Res
; 24(18): 4399-4406, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848572
11.
Bilateral marginal keratitis associated with engraftment syndrome after hematopoietic stem cell transplantation.
Cornea
; 26(6): 756-8, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17592333
12.
A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.
Clin Lymphoma Myeloma Leuk
; 16(3): 139-45, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26775883
13.
Management of primary intraocular lymphoma.
Curr Oncol Rep
; 7(1): 74-9, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15610690
14.
Ocular graft vs. host disease.
Ocul Surf
; 3(4 Suppl): S177-9, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17216114
15.
Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium.
Ocul Surf
; 3(4 Suppl): S131-8, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17216102
16.
International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I).
Sci Rep
; 3: 3419, 2013 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24305504
17.
Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis).
Trans Am Ophthalmol Soc
; 110: 64-73, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23818735
18.
Optic neuropathy secondary to sub-tenon anesthetic injection in cataract surgery.
Arch Ophthalmol
; 121(6): 907-9, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12796271
19.
Update on ocular graft versus host disease.
Curr Opin Ophthalmol
; 17(4): 344-8, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16900025
20.
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.
Biol Blood Marrow Transplant
; 12(1): 31-47, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16399567